Skip to content

e-Health Psychosocial Stress and Symptom Management (ePSMI) for Pancreatic Cancer Patients

Development of an eHealth Psychosocial Stress and Symptom Management Intervention for Patients With Pancreatic Cancer

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06893276
Enrollment
60
Registered
2025-03-25
Start date
2026-08-13
Completion date
2027-11-27
Last updated
2026-08-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancreatic Cancer

Brief summary

The purpose of this research is to evaluate a new, web-based program among patients with pancreatic cancer aimed at reducing psychosocial stress.

Interventions

BEHAVIORALePSMI

Participants will complete an hour of cognitive behavioral stress management program in person or remote each week for ten weeks. The cognitive behavioral therapy (CBT) skills target reducing anxiety, (e.g., relaxation), changing negative appraisals (e.g., cognitive restructuring), coping skills training (e.g., enhancing adaptive skills), behavioral activation, interpersonal skills (e.g., communication skills) and building or enhancing social networks. The intervention will be administered online, and each module will last about 1-hour. After module completion, participants will have access to modules covered during session.

Sponsors

University of Miami
Lead SponsorOTHER
U.S. Army Medical Research and Development Command
CollaboratorFED

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
SUPPORTIVE_CARE
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

1. Greater than 18 years of age. 2. Spanish or English speaker with ability to read one of these languages. 3. Diagnosis of pancreatic cancer. 4. Patients diagnosed with pancreatic neuroendocrine tumor (PNET).

Exclusion criteria

1. Patients unable to read Spanish or English, as participants will not be unable to complete surveys. 2. Have a history of severe psychiatric illness (e.g., psychosis, active suicidality, inpatient treatment in the past 12 months). 3. Have any condition that, in the opinion of the investigator, would compromise the well-being of the patient or the study or prevent the patient from meeting or performing study requirements.

Design outcomes

Primary

MeasureTime frameDescription
Patient-Reported Outcomes Measurement Information System - Fatigue Short FormUp to 10 weeks.Scores will range 0-80 with higher scores indicating higher fatigue symptoms
Pittsburgh Sleep Quality Index (PSQI)Up to 10 weeks.Scores will range from 0-21 with higher scores indicating worse sleep quality.
Gastrointestinal Symptom Rating Scale (GSRS)Up to 10 weeks.Scores will range from 0-78 with higher scores indicating worse gastrointestinal symptoms.
Patient-Reported Outcomes Measurement Information System - Pain Short FormUp to 10 weeks.Scores will range 0-80 with higher scores indicating higher pain symptoms
Percentage of Participants RecruitedUp to 1 year.Will be measured in percentages (%). The study will be considered feasible passed 60%.
Percentage of Participants RetainedUp to 1 year.Will be measured in percentages (%). The study will be considered feasible passed ≥ 80%.
Percentage of Study ParticipationUp to 1 year.Will be measured in percentages (%). The study will be considered feasible passed ≥ 80%.
Number of CallsUp to 10 weeks.It will be measured by number of biweekly calls.
Theoretical Framework on Acceptability QuestionnaireUp to 10 weeks.Scores will range from 10-50. Higher scores indicate higher acceptability.
Functional Assessment of Cancer Therapy (FACT) - Functional Hepatobiliary-Pancreatic Symptom Index (FHSI)-18Up to 10 weeks.Scores will range 0-72 with lower scores indicating better quality of life.

Secondary

MeasureTime frameDescription
Patient-Reported Outcomes Measurement Information System - Depression Short FormUp to 10 weeks.Scores will range 0-80 with higher scores indicating higher pain symptoms
Patient-Reported Outcomes Measurement Information System - Anxiety Short FormUp to 10 weeks.Scores will range 0-80 with higher scores indicating higher pain symptoms
Patient-Reported Outcomes Measurement Information System - Physical Functioning Short FormUp to 10 weeks.Scores will range 0-80 with higher scores indicating higher pain symptoms
Patient-Reported Outcomes Measurement Information System - Self- Efficacy for Managing Symptoms-Short Form 8aUp to 10 weeks.Scores will range 8-40 with greater scores indicating greater self- efficacy for managing symptoms.
Emotional distress measured by Measure of Current State ScaleUp to 10 weeks.Scores will range from 0-80 with higher scores indicating more intense emotional distress.
Difficulties in Emotional Regulation ScaleUp to 10 weeks.Scores will range from 18-90 with higher scores indicating less emotional regulation.
Intolerance of Uncertainty ScaleUp to 10 weeks.Scores will range from 27-135 with higher scores indicated greater intolerance of uncertainties.
Cancer Behavior InventoryUp to 10 weeks.Scores will range from 33-297 with higher scores indicating greater self-efficacy in coping with cancer.
Emotional Bond subscale of the Multiperspective Assessment of General Change Mechanisms in Psychotherapy (MPACM-P)Up to 10 weeks.Scores will range from, 5-25; higher scores indicate greater emotional connection between the therapist and patient.
Agreement of Collaboration Subscale of the Multiperspective Assessment of General Change Mechanisms in Psychotherapy (MPACM-P)Up to 10 weeks.Scores will range from, 5-25; higher scores indicate greater agreement on collaboration between the therapist and patient.
Length of Hospital StayUp to 365 days.Measured in number of days.
Number of Participant's ReadmissionsUp to 1 year.Measured in number of readmissions.
Number of Reoccurrence of Disease in ParticipantsUp to 1 year.Responses will be binary (yes or no). Will be measured in numbers.
Progression of DiseaseUp to 1 year.Stages range from 0 to 4. Stage 0: carcinoma in situa Stage 1: localized Stage II: locally advanced Stage III: locally advanced with major blood vessel involvement Stage IV: Metastatic
Perceived Stress ScaleUp to 10 weeks.Scores will range from 0 to 40 with higher scores indicating greater perceived stress levels.
University of California, Los Angeles (UCLA) Loneliness ScaleUp tp 10 weeks.Scale of 20-80 with higher scores indicating higher loneliness
Interpersonal Support Evaluation ListUp tp 10 weeks.12 item questionnaire evaluated on a 4-point Likert scale with a higher score indicating higher support

Countries

United States

Contacts

CONTACTSara Fleszar-Pavlovic, PhD
sarafleszarpavlovic@med.miami.edu305-243-8498
PRINCIPAL_INVESTIGATORFrank Penedo, PhD

University of Miami

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Aug 27, 2026